Short-Term Use of Upadacitinib in Combination With Biologic Therapy for Inducing Clinical Remission in Patients With Active Inflammatory Bowel Disease.
Jianyi YinYassin El-NajjarNoelle CordovaMary-Joe ToumaNoelle NguyenMoheb BoktorEzra BursteinDavid I FudmanPublished in: Inflammatory bowel diseases (2024)